IVD Parasitic Infection - Immunity: E. histolytica IgG, Fasciola IgG, Schistosoma IgG, Toxocara IgG, Echinococcus IgG - Vietnam Registration 240002561/PCBB-HCM
Access comprehensive regulatory information for IVD Parasitic Infection - Immunity: E. histolytica IgG, Fasciola IgG, Schistosoma IgG, Toxocara IgG, Echinococcus IgG in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TBYT Loại B medical device is registered under number 240002561/PCBB-HCM and manufactured by ImmunoCentrix. The authorized representative in Vietnam is CÔNG TY TNHH THƯƠNG MẠI DỊCH VỤ HASPHARM.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
240002561/PCBB-HCM
000.00.19.H29-241101-0031
Theo theo phụ lục
Theo phụ lục
Technical Details
1. E. histolytica IgG: ImmunoCentrix E. histolytica ELISA is an enzyme-linked immunosorbent assay (ELISA) test for the qualitative detection of antibodies against E. histolytica in human serum or plasma samples. This test is performed only by trained medical laboratory technicians. 2. Fasciola (hepatica) IgG: ImmunoCentrix Fasciola IgG is used to screen serum for qualitative detection of IgG antibodies against Fasciola hepatica by the enzyme-linked immunosorbent assay (ELISA) technique. 3. Schistosoma IgG: ImmunoCentrix Schistosoma IgG is used to determine qualitative serum antibodies in humans, primarily IgG, against Schistosoma spp. by the ELISA technique. 4. Toxocara IgG: ImmunoCentrix Toxocara IgG ELISA is an enzyme-linked immunosorbent assay (ELISA) test for the qualitative detection of antibodies against Toxocara in human serum or plasma samples. This test is performed only by trained medical laboratory technicians. 5. Echinococcus IgG: ImmunoCentrix Echinococcus IgG is used to screen serum for qualitative detection of IgG antibodies against Echinococcus sp. by the enzyme-linked immunosorbent assay (ELISA) technique.
Dates and Status
Nov 08, 2024

